For example, the deletion of the DACH1 gene occurs in up to 18% of human prostate cancer cases, and its loss in mouse prostate cancer models has been shown to enhance prostatic intraepithelial neoplasia and DNA damage [6]. This evidence concerns the gene DACH1 and prostate cancer.